Roche's Bid to Acquire Illumina Topped Readers' Interest in 2012 | GenomeWeb

NEW YORK (GenomeWeb News) – Roche's bid to acquire Illumina, which was ultimately unsuccessful in the early part of 2012, topped our list of most-viewed articles on GenomeWeb Daily News for the year.

A series of articles on Roche's pursuit and Illumina's efforts to fend off the hostile takeover bid claimed six of the top 10 most-viewed articles on GWDN for 2012:

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Nucleic Acids Research this week: transcriptome patterns of Zika-infected cells, updated Comparative Toxicogenomics Database, and more.

BMJ study says that about half of former hematology-oncology regulators now work for industry.

Science should wish PhDs who leave academia well, a Nature editorial says.

New York-based doctors announce the birth of a baby boy whose parents underwent mitochondrial transfer therapy, New Scientist reports.